Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC

Launched by I.R.C.C.S OSPEDALE GALEAZZI-SANT'AMBROGIO · Dec 7, 2017

Keywords

ClinConnect Summary

This clinical trial is looking at the effects of a specific treatment called AMIC (Autologous Matrix Induced Chondrogenesis) for people with painful osteochondral lesions, which are injuries to the cartilage and bone in the ankle. The goal is to see how well this all-arthroscopic technique works in improving both the symptoms and the imaging results for patients who have undergone this surgery.

To participate in this study, you need to be over 18 years old and have had the AMIC procedure for a talar (ankle) injury. Unfortunately, if you have had previous surgery on your affected ankle or are under 18, you wouldn’t be eligible for this trial. If you decide to join, you can expect to undergo evaluations to track your recovery and the effectiveness of the treatment over time. This trial is currently recruiting participants of all genders, so there’s an opportunity for many individuals to contribute to understanding how this treatment can help others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age over 18 years
• • males and females
• • patients underwent arthroscopic cartilage reconstruction surgery with AMIC technique for osteochondral lesions of the talus
• Exclusion Criteria:
• • age \<18 years at the time of surgery
• • patients with previous surgery on the affected ankle